matrix
-
Biologics
Biogennix Launches Agilon Surgical Matrix
Osteobiologics Leader Enters Wound Care Space with Cutting Edge Solution IRVINE, Calif., July 24, 2024 – OrthoSpineNews – Biogennix, an…
Read More » -
Top Stories
Xenco Medical Unveils the TrabeculeX Continuum, a Breakthrough Convergence of Digital Health and Biomaterials
January 16, 2024 – OrthoSpineNews –Trailblazing medical technology company Xenco Medical has unveiled TrabeculeX Continuum, a novel convergent technology bridging…
Read More » -
Biologics
Biogennix Launches OsteoSPAN Fiber Matrix
IRVINE, Calif., October 24, 2023 / OrthoSpineNews / – Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary…
Read More » -
Biologics
AlloSource Launches AlloMend Duo Acellular Dermal Matrix, A Natural Solution For Non-Directional Implantation In Soft Tissue Reconstruction
CENTENNIAL, Colo., May 25, 2023 /PRNewswire/ — AlloSource®, one of the largest nonprofit allograft providers in the U.S. creating innovative cellular and…
Read More » -
Biologics
AlloSource Launches Allomend Extra-large Acellular Dermal Matrix
New dermal graft has the largest footprint within the AlloMend product line to support demanding soft tissue applications in plastic…
Read More » -
Biologics
Fuse Medical, Inc. Announces Official Launch of FuseChoice™ Dermal Matrix
September 9, 2021 RICHARDSON, Texas–(BUSINESS WIRE)–Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”), an emerging manufacturer and distributor of…
Read More » -
Biologics
Prosidyan® FIBERGRAFT® Achieves High Fusion Rate in Multi-Center Clinical Study Presented at Top Neurosurgery Conference
FIBERGRAFT® BG Matrix Achieved 96.3% Fusion Rate in Posterolateral Spine Fusion Clinical Study NEW PROVIDENCE, N.J. (PRWEB) AUGUST 26, 2021 Prosidyan,…
Read More » -
Biologics
AlloSource Launches AlloMend Ultra-Thick Acellular Dermal Matrix
New allograft is the thickest in the AlloMend product line to support demanding soft tissue applications CENTENNIAL, Colo., Aug. 11, 2021 /PRNewswire/…
Read More » -
Biologics
Use of ViviGen® Cellular Bone Matrix results in significantly lower hospital costs compared to rhBMP-2
VIRGINIA BEACH, Va., Nov. 23, 2020 /PRNewswire/ — ViviGen® Cellular Bone Matrix is associated with significantly lower hospital costs compared to recombinant human bone morphogenetic protein-2…
Read More » -
Biologics
Spine Wave Announces the Commercial Launch of Tornado® Bioactive Bone Graft Matrix
SHELTON, Conn., Sept. 24, 2020 (GLOBE NEWSWIRE) — Spine Wave is pleased to announce the commercial launch of Tornado® Bioactive Bone…
Read More » -
Biologics
Spine Wave Announces the Commercial Launch of Tempest® Allograft Bone Matrix
SHELTON, Conn., July 14, 2020 (GLOBE NEWSWIRE) — Spine Wave is pleased to announce the successful completion of a limited…
Read More » -
Biologics
Integra LifeSciences Announces Positive Clinical Results for Integra® Bilayer Wound Matrix (IBWM)
PRINCETON, N.J., May 15, 2020 (GLOBE NEWSWIRE) — Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company, today announced…
Read More » -
Biologics
LifeNet Health Expands Operations in the Pacific Northwest to Include Production of ViviGen® Cellular Bone Matrix
January 10, 2017 RENTON, Wash.–(BUSINESS WIRE)–LifeNet Health, the only full-service, non-profit tissue bank operating in the Pacific Northwest, has begun…
Read More » -
Financial
Collagen Matrix, Inc. Names Oystein Valberg as Chief Financial Officer
OAKLAND, N.J., Nov. 22, 2016 /PRNewswire/ — Collagen Matrix, Inc., which advances the science of tissue repair and regeneration by…
Read More » -
Biologics
Integra LifeSciences Organizes Hands-on Wound Workshop on Best Practices for Omnigraft® Dermal Regeneration Matrix and PriMatrix® Dermal Repair Scaffold at Symposium on Advanced Wound Care (SAWC) Fall Meeting
PLAINSBORO, N.J., Oct. 17, 2016 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq:IART) recently organized a hands-on regenerative wound management workshop…
Read More »